Peroxisome proliferator activated receptor ligands for the treatment of insulin resistance

Tools

Patsouris, David, Müller, Michael and Kersten, Sander (2004) Peroxisome proliferator activated receptor ligands for the treatment of insulin resistance. Current Opinion in Investigational Drugs, 5 (10). pp. 1045-1050. ISSN 1472-4472

Full text not available from this repository. (Request a copy)

Abstract

Peroxisome proliferator activated receptors (PPARs) are a group of ligand-activated transcription factors that play critical roles in the regulation of energy metabolism. Synthetic agonists for these receptors are used in the treatment of type 2 diabetes mellitus and dyslipidemia. Current data linking PPAR and/or PPAR ligands with the treatment of insulin resistance will be critically reviewed, with the focus on important advances over the past year.

Item Type:	Article
Uncontrolled Keywords:	animals,diabetes mellitus, type 2,humans,hypoglycemic agents,insulin resistance,ligands,peroxisome proliferator-activated receptors,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Nutrition and Preventive Medicine Faculty of Medicine and Health Sciences > Research Groups > Gastroenterology and Gut Biology Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Related URLs:	https://pubmed.ncbi.nlm.nih.gov/15535425...
Depositing User:	Pure Connector
Date Deposited:	07 Jul 2014 12:04
Last Modified:	28 Jan 2025 15:28
URI:	https://ueaeprints.uea.ac.uk/id/eprint/47746
DOI:

Actions (login required)

View Item